Kaiser Permanente staff considering a strike; what can medicine do for people with genes for ALS?

More than 75,000 Kaiser Permanente health care workers have voted to authorize a strike if the two sides can't reach a deal.

September 21, 2023 Check out STAT+

Sponsored By

Constanza Hevia for STAT STAT+ | They carry a gene for ALS but aren't sick. What does medical research owe them? A new movement is pushing the medical and research world to include people with genetic mutations for ALS for the first time. By Jason Mast STAT+ | Four burning questions about the potential 85,000-worker Kaiser Permanente strike More than 75,000 Kaiser Permanente health care workers have voted to authorize a strike if the two sides can't reach a deal. By Brittany Trang FTC sues private equity firm Welsh Carson, U.S. Anesthesia Partners for allegedly creating a monopoly Federal Trade Commission says U.S. Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, tried to raise prices, boost profits. By Bob Herman and Tara Bannow Adobe STAT+ | What to know about the polarizing ALS drug headed for FDA scrutiny next week Critics want more data on stem-cell therapy NurOwn. ALS advocates say the needs of patients should be top priority in approving new drugs. By Damian Garde STAT+ | Bernie Sanders, Bill Cassidy clash over proposal to increase primary care doctors, nurses Sens. Bernie Sanders and Bill Cassidy clashed over a proposal to increase the number of primary care doctors and nurses in the United States. By Rachel Cohrs Opinion: Brain drain, skills loss, and other unintended consequences of overturning Roe v. Wade My podcast, "The Nocturnists," interviewed abortion providers across the country. We learned some surprising things. By Alison Block Wikimedia Commons AlphaFold developers and eye scan inventors among Lasker Award winners for 2023 The winners of the 2023 Lasker Awards distinguished themselves with AI-enabled protein modeling and groundbreaking eye scans. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser